MediciNova, Inc.
METHODS OF SUPPRESSING MYELOID-DERIVED SUPPRESSOR CELLS IN PATIENTS

Last updated:

Abstract:

Methods of suppressing myeloid-derived suppressor cells (MDSCs), reducing immune suppression, reducing regulatory T-cell count and increasing CD4+ T-cell count in cancer patients using ibudilast.

Status:
Application
Type:

Utility

Filling date:

31 Jul 2020

Issue date:

17 Jun 2021